摘要 |
The invention provides adamantane derivatives represented by formula (I), a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy. In said formula (I), A represents a group CH2 or an oxygen atom; B represents a hydrogen or halogen atom; D represents a group CH2, OCH2, NHCH2 or CH2CH2; R represents a phenyl, benzothiazolyl, indolyl, indazolyl, purinyl, pyridyl, pyrimidinyl or thiophenyl group, each of which may be optionally substituted by one or more substituents.
|